Immersive Virtual Reality during Robot-Assisted Gait Training: Validation of a New Device in Stroke Rehabilitation.

cybersickness gait rehabilitation head-mounted display robot-assisted gait training virtual reality

Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
07 Dec 2022
Historique:
received: 29 09 2022
revised: 26 11 2022
accepted: 01 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Background and objective: Duration of rehabilitation and active participation are crucial for gait rehabilitation in the early stage after stroke onset. Virtual reality (VR) is an innovative tool providing engaging and playful environments that could promote intrinsic motivation and higher active participation for non-ambulatory stroke patients when combined with robot-assisted gait training (RAGT). We have developed a new, fully immersive VR application for RAGT, which can be used with a head-mounted display and wearable sensors providing real-time gait motion in the virtual environment. The aim of this study was to validate the use of this new device and assess the onset of cybersickness in healthy participants before testing the device in stroke patients. Materials and Methods: Thirty-seven healthy participants were included and performed two sessions of RAGT using a fully immersive VR device. They physically walked with the Gait Trainer for 20 min in a virtual forest environment. The occurrence of cybersickness, sense of presence, and usability of the device were assessed with three questionnaires: the Simulator Sickness Questionnaire (SSQ), the Presence Questionnaire (PQ), and the System Usability Scale (SUS). Results: All of the participants completed both sessions. Most of the participants (78.4%) had no significant adverse effects (SSQ < 5). The sense of presence in the virtual environment was particularly high (106.42 ± 9.46). Participants reported good usability of the device (86.08 ± 7.54). Conclusions: This study demonstrated the usability of our fully immersive VR device for gait rehabilitation and did not lead to cybersickness. Future studies should evaluate the same parameters and the effectiveness of this device with non-ambulatory stroke patients.

Identifiants

pubmed: 36557007
pii: medicina58121805
doi: 10.3390/medicina58121805
pmc: PMC9782023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Neuroeng Rehabil. 2017 Feb 21;14(1):16
pubmed: 28222783
Iperception. 2017 May 18;8(3):2041669517708205
pubmed: 28567271
Front Neurol. 2019 Oct 10;10:1061
pubmed: 31649608
J Neuroeng Rehabil. 2021 Apr 22;18(1):68
pubmed: 33888148
Eur J Phys Rehabil Med. 2021 Apr;57(2):227-237
pubmed: 33541040
Expert Rev Med Devices. 2018 Feb;15(2):107-117
pubmed: 29313388
Front Neurol. 2021 Jun 08;12:650024
pubmed: 34168608
Neurophysiol Clin. 2015 Nov;45(4-5):335-55
pubmed: 26547547
Front Hum Neurosci. 2020 Mar 31;14:96
pubmed: 32300295
Brain Res Bull. 1998 Nov 15;47(5):507-16
pubmed: 10052582
Curr Atheroscler Rep. 2017 Nov 7;19(12):59
pubmed: 29116473
Gerontologist. 2018 May 8;58(3):478-487
pubmed: 28329867
Neurorehabil Neural Repair. 2001;15(1):39-50
pubmed: 11527278
Arch Phys Med Rehabil. 1995 Jan;76(1):27-32
pubmed: 7811170
Front Psychol. 2018 Nov 06;9:2132
pubmed: 30459688
Games Health J. 2018 Jun;7(3):151-156
pubmed: 29293369
Ann Phys Rehabil Med. 2020 Nov;63(6):518-534
pubmed: 32229177
Front Robot AI. 2020 Jan 31;7:4
pubmed: 33501173
Psychol Belg. 2021 Jun 03;61(1):145-162
pubmed: 34131490
J Neuroeng Rehabil. 2018 Apr 25;15(1):35
pubmed: 29695280
Front Psychol. 2019 Feb 04;10:158
pubmed: 30778320
J Neuroeng Rehabil. 2017 Jun 7;14(1):53
pubmed: 28592282
J Geriatr Phys Ther. 2019 Oct/Dec;42(4):256-264
pubmed: 29324509
J Rehabil Med. 2009 Sep;41(9):734-9
pubmed: 19774307
Am J Phys Med Rehabil. 2019 Sep;98(9):783-788
pubmed: 30964752
Front Neurol. 2022 May 03;13:855226
pubmed: 35592466
Multisens Res. 2018 Jan 1;31(7):645-674
pubmed: 31264611
Cochrane Database Syst Rev. 2020 Oct 22;10:CD006185
pubmed: 33091160
Front Med (Lausanne). 2020 Jan 15;6:329
pubmed: 32010701
Eur J Phys Rehabil Med. 2018 Jun;54(3):397-407
pubmed: 29265791

Auteurs

Charles Morizio (C)

HAVAE Laboratory, UR20217, University of Limoges, F-87000 Limoges, France.
Department of Physical Medicine and Rehabilitation, University Hospital Center of Limoges, F-87000 Limoges, France.

Maxence Compagnat (M)

HAVAE Laboratory, UR20217, University of Limoges, F-87000 Limoges, France.
Department of Physical Medicine and Rehabilitation, University Hospital Center of Limoges, F-87000 Limoges, France.

Arnaud Boujut (A)

HAVAE Laboratory, UR20217, University of Limoges, F-87000 Limoges, France.
3iL Groupe, F-87015 Limoges, France.

Ouiddad Labbani-Igbida (O)

XLim Institute, UMR CNRS 7252, University of Limoges, F-87068 Limoges, France.

Maxime Billot (M)

PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, F-86000 Poitiers, France.

Anaick Perrochon (A)

HAVAE Laboratory, UR20217, University of Limoges, F-87000 Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH